0
Special Feature
Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective
Alkiviadis G. Nacopoulos, PharmD; Andrea J. Lewtas, PharmD; Maria M. Ousterhout, PharmD
J Am Pharm Assoc (2003) 2010;50:148-157. doi:10.1331/JAPhA.2010.09178

Abstract

Objective  To present a summary of the existing literature on syringe exchange programs (SEPs) and to discuss the potential role of pharmacists in providing support for injection drug users (IDUs) and such programs.

Data sources  To identify relevant articles published since 2000, a search of PubMed and Medline was conducted using syringe exchange programs and needle exchange programs as search terms. A manual review of each article's citation list was also conducted.

Data extraction  By the authors.

Data synthesis  Information is presented in four categories: state and federal support of SEPs, characteristics of SEP users, epidemiological studies, and social reluctance for SEP support. The information summarized in these sections is then used as a foundation for a review of the potential role of the pharmacist.

Conclusion  SEPs have demonstrated a clear effect in improving the health outcomes of IDUs by decreasing the transmission of blood-borne disease and lowering high-risk injecting behaviors. Despite conflicting support for SEPs at both the federal and local levels, pharmacists can play a pivotal role in the health of IDUs by providing sound medical advice and, in some states, acting as an alternative channel for obtaining clean syringes. Efforts should continue to focus on educating pharmacists about this role and how their individual actions can benefit the health of the entire population.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. 2006 disease profile. Accessed at www.cdc.gov/nchhstp/Publications/docs/2006_Disease_Profile_508_FINAL.pdf, September 24,  2009.
 
 Centers for Disease Control and Prevention. A comprehensive approach: Preventing blood-borne infections among injection drug users. Accessed at www.cdc.gov/IDU/pubs.htm, September 24,  2009.
 
Ferrini R. American College of Preventive Medicine public policy on needle-exchange programs to reduce drug-associated morbidity and mortality Am J Prev Med. 2000;18:173–5.[PubMed][CrossRef]
 
Battles HB, Rowe KA, Ortega-Peluso C, et al. Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP) J Urban Health. 2009;86:946–50.[PubMed]
 
 World Health Organization. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDs among injecting drug users. Accessed at www.who.int/hiv/pub/idu/pubidu/en, September 24,  2009.
 
 Centers for Disease Control and Prevention. Syringe exchange programs. Accessed at www.cdc.gov/idu/facts/AED_IDU_SYR.pdf, September 24,  2009.
 
Henry J. Kaiser Family Foundation Sterile syringe exchange programs, 2005. Accessed at www.statehealthfacts.org/comparemapdetail.jsp?ind=566&cat=11&sub=130&yr=16&typ=5, September 24,  2009.
 
 North American Syringe Exchange Program. U.S. Syringe Exchange Program Database. Accessed at www.nasen.org/programs, October 20,  2009.
 
Brahmbhatt H, Bigg D, Strathdee SA. Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998 J Urban Health. 2000;77:346–58.[PubMed]
 
Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: Epidemiology and policy Am J Epidemiol. 2001;154(12 suppl):S70–7.[PubMed]
 
 Medical News Today. House passes spending bill; amendment to block removal of needle exchange funding ban defeated. Accessed at www.medicalnewstoday.com/articles/158985.php, October 16,  2009.
 
 Library of Congress. 111th Congress, 1st session, H.R.3293. Accessed at http://thomas.loc.gov/cgi-bin/query/C?c111:./temp/˜c111rNfHHd, October 16,  2009.
 
 Tapestry Health Systems. House votes to end federal funding ban for syringe exchange. Accessed at http://teens.tapestryhealth.org/index.php/2009/12/house-votes-to-end-federal-funding-ban-for-syringe-exchange, January 11,  2010.
 
Dillon P. Needle exchange ban lifted; ball's in Rell's court. Accessed at www.newhavenindependent.org/HealthCare/archives/2009/12/needle_exchange_1.php, January 11,  2010.
 
 Aids Action. AIDS Action applauds Congress for historic end to twenty year ban on the use of federal funds for syringe exchange. Accessed at www.aidsaction.org/news-room-mainmenu-182/press-releases-mainmenu-342/45-press-releases-2009-/553-washington-december-13-2009, January 11,  2010.
 
Turnberg WL, Kones TS. Community syringe collection and disposal policies in 16 states J Am Pharm Assoc. 2002;42(suppl 2):S99–104.
 
 Centers for Disease Control and Prevention. State and local policies regarding IDUs’ access to sterile syringes. Accessed at www.cdc.gov/idu/facts/aed_idu_pol.pdf, September 28,  2009.
 
 Temple University Beasley School of Law. Law, policy & public health at Temple University's Beasley School of Law: Non-prescription access to sterile syringes. Accessed at www.temple.edu/lawschool/phrhcs/otc.htm, October 23,  2009.
 
Riley ED, Wu AW, Junge B, et al. Health services utilization by injection drug users participating in a needle exchange program Am J Drug Alcohol Abuse. 2002;28:497–511.[PubMed]
 
Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco Subst Use Misuse. 2005;40:1681–96.[PubMed]
 
Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy J Acquir Immune Defic Syndr Hum Retrovirol. 2001;28:237–78.
 
Hagan H, Des Jarlais DC, Friedman SR, et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma Syringe Exchange Program Am J Public Health. 1995;85:1531–7.[PubMed]
 
Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users AIDS. 2001;15:1329–41.[PubMed]
 
Ouellet L, Dezheng H, Bailey S. HIV risk practices among needle exchange users and nonusers in Chicago Epidemiology and Social Science. 2004;37:1187–96.
 
Riley ED, Safaeian M, Strathdee SA, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program J Acquir Immune Defic Syndr. 2000;24:57–61.[PubMed]
 
Hagan H, McGough JP, Thiede H, et al. Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs J Urban Health. 2000;77:103–11.[PubMed]
 
Fischer DG, Reynolds GL, Harbke CR. Selection effect of needle exchange in Anchorage, Alaska J Urban Health. 2002;79:128–35.[PubMed]
 
Holtzman D, Barry V, Ouellet LJ, et al. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004 Prev Med. 2009;49:68–73.[PubMed]
 
Neaigus A, Zhao M, Gyarmathy A, et al. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are Illegal J Urban Health. 2008;85:309–22.[PubMed]
 
Longshore D, Bluthenthal RN, Stein MD. Needle exchange program attendance and injection risk in Providence, Rhode Island AIDS Educ Prev. 2001;13:78–90.[PubMed]
 
Bailey SL, DeZheng H, Garfein RS, et al. The use of needle exchange by young injection drug use J Acquir Immune Defic Syndr. 2003;34:67–70.[PubMed]
 
Huo D, Ouellet LJ. Needle exchange and injection-related risk behaviors in Chicago J Acquir Immune Defic Syndr. 2007;45:108–14.[PubMed]
 
Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program J Urban Health. 2000;77:369–82.[PubMed]
 
Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders AIDS Educ Prev. 2003;15:257–68.[PubMed]
 
Gibson DR, Brand R, Ander K, et al. Two- to sixfold decreased odds of hiv risk behavior associated with use of syringe exchange J Acquir Immune Defic Syndr. 2002;31:237–42.[PubMed]
 
Bluthenthal RN, Kral AH, Gee L, et al. The effect of syringe exchange use on high-risk injection drug users: A cohort study AIDS. 2000;14:605–11.[PubMed]
 
Huo D, Ouellet LJ. Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois Sex Transm Dis. 2009;36:35–40.[PubMed]
 
Masson Cl, Sorensen JL, Perlman DC, et al. Hospital- versus community-based syringe exchange: A randomized controlled trial AIDS Educ Prev. 2007;19:91–110.
 
Braine N, Des Jarlais DC, Ahmad S, et al. Long-term effects of syringe exchange on risk behavior and HIV prevention AIDS Educ Prev. 2004;16:264–75.[PubMed]
 
 Centers for Disease Control and Prevention. Pharmacy sales of sterile syringes. Accessed at www.cdc.gov/idu/facts/aed_idu_phar.pdf, September 28,  2009.
 
Taussig J, Junge B, Burris S, et al. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia J Am Pharm Assoc. 2002;42(suppl 2):S40–5.
 
Taussig JA, Weinstein B, Burris S, et al. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US AIDS. 2000;14(suppl 1):S47–51.[PubMed]
 
Reich W, Compton WM, Horton JC, et al. Pharmacist ambivalence about sale of syringes to injection drug users J Am Pharm Assoc. 2002;42(suppl 2):S52–7.
 
Rich JD, Martin EG, Macalino GE, et al. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island J Am Pharm Assoc. 2002;42(suppl 2):S58–61.
 
Lewis BA, Koester SK, Bush TW. Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado J Am Pharm Assoc. 2002;42(suppl 2):S46–51.
 
Deibert RJ, Goldbaum G, Parker TR. Increased access to unrestricted pharmacy sales of syringes in Seattle-King county, Washington: Structural and individual-level changes, 1996 versus 2003 Am J Public Health. 2006;96:1347–53.[PubMed]
 
Jones TS, Coffin PO. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal J Am Pharm Assoc. 2002;42(6 suppl 2):S6–9.
 
Pouget ER, Deren S, Fuller C, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program J Acquir Immune Defic Syndr. 2005;39:471–7.[PubMed]
 
Burris S, Vernick JS, Ditzler A, et al. The legality of selling or giving syringes to injection drug users J Am Pharm Assoc. 2002;42(suppl 2):S13–8.
 
Wolfe T, Amelunxen V, Torres D, et al. Encouraging pharmacy sale of syringes to injection drug users in New Mexico J Am Pharm Assoc. 2002;42(suppl 2):S32–3.
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints